Showing results (431-440 of 455) with videos related to
Sort By:
Pageof 46
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2019
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell TransplantationBetty K Hamilton, Ying Liu, Michael T Hemmer, et al.Blood Advances|July 1, 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemiaMark J Levis, Mehdi Hamadani, Brent R Logan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remissionErica D Warlick, Kristjan Paulson, Ruta Brazauskas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3Mark J Levis, Mehdi Hamadani, Brent Logan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 29, 2013
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant researchVikas Gupta, Adriana K Malone, Parameswaran N Hari, et al.Blood|September 26, 2013
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBIEdward A Copelan, Betty K Hamilton, Belinda Avalos, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiationEdward A Copelan, Belinda R Avalos, Kwang Woo Ahn, et al.Research and Practice in Thrombosis and Haemostasis|April 3, 2025
Illustrated capsules from the Advanced Course in Platelet ResearchChristian Andrea Di Buduo, Vittorio Abbonante, Alessandro Malara, et al.Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.Pageof 46